Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide

被引：14

作者：

Montagut, C ^{[1
]}

Bosch, F ^{[1
]}

Villela, L ^{[1
]}

Rosiñol, L ^{[1
]}

Bladé, J ^{[1
]}

机构：

[1] Univ Barcelona, Hosp Clin, IDIBAPS, ICMHO,Dept Hematol, E-08036 Barcelona, Spain

来源：

LEUKEMIA & LYMPHOMA | 2004年 / 45卷 / 08期

关键词：

multiple myeloma; thalidomide; aminoglycoside; renal failure;

D O I：

10.1080/10428190310001638841

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thalidomide has been proved to play an important role in rescue treatment of patients with refractory/relapsed multiple myeloma (MM). However, thalidomide therapy is associated with numerous side effects, mainly somnolence, constipation, fatigue or peripheral neuropathy. We report three patients diagnosed with MM and treated with thalidomide as salvage therapy who developed severe renal failure when they received aminoglycoside antibiotics. This observation suggests that thalidomide can potentiate nephrotoxicity of aminoglycoside antibiotics in patients with MM.

引用

页码：1711 / 1712

页数：2

共 50 条

[31] EDA-V in advanced multiple myeloma patients previously treated with thalidomide
Polloni, C.
Offidani, M.
Corvatta, L.
Piersantelli, M. N.
Catarini, M.
Brunori, M.
Alesiani, F.
Burattini, M.
Leoni, P.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 145 - 146
[32] Prognostic value of selected chromosomal abnormalities in multiple myeloma patients treated by thalidomide
Zaoralova, R.
Greslikova, H.
Filkova, H.
Nemec, P.
Kuglik, P.
Oltova, A.
Pour, L.
Adam, Z.
Krivanova, A.
Krejci, M.
Hajek, R.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 170 - 170
[33] Factors associated with renal failure and renal function recovery in multiple myeloma
Yikilmaz, A. Senturk
Bakanay, S.
Akinci, S.
Gunduz, M.
Dilek, I.
LEUKEMIA RESEARCH, 2018, 73 : S29 - S29
[34] Thalidomide-associated thrombosis in multiple myeloma
Altintas, Abdullah
Cil, Timucin
Ayyildiz, Orhan
Kaplan, Mehmet A.
Atay, Ahmet E.
Isikdogan, Abdurrahman
Muftuoglu, Ekrem
ANNALS OF ONCOLOGY, 2006, 17 : 211 - 211
[35] Multiple myeloma, severe hypercalcaemia, acute renal failure and multiple organ failure due to calcicosis
Martinez Mateu, J. G.
Losada Gonzalez, G. P.
Munar Vila, M. A.
Uriol Rivera, M.
Gomez Marques, G.
Tugores, A. C.
NEFROLOGIA, 2011, 31 (02): : 233 - 234
[36] The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea
Kim, Cheolsu
Lee, Ho Sup
Min, Chang-Ki
Lee, Je Jung
Kim, Kihyun
Yoon, Dok Hyun
Eom, Hyeon Seok
Lee, Hyewon
Lee, Won Sik
Shin, Ho-Jin
Lee, Ji Hyun
Park, Yong
Jo, Jae-Cheol
Do, Young Rok
Mun, Yeung-Chul
KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (05): : 675 - 683
[37] Neuropathy in multiple myeloma treated with thalidomide - A prospective study
Plasmati, R.
Pastorelli, F.
Cavo, M.
Petracci, E.
Zamagni, E.
Tosi, P.
Cangini, D.
Tacchetti, P.
Salvi, F.
Bartolomei, I.
Michelucci, R.
Tassinari, C. A.
NEUROLOGY, 2007, 69 (06) : 573 - 581
[38] High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
Broyl, Annemiek
Kuiper, Rowan
van Duin, Mark
van der Holt, Bronno
el Jarari, Laila
Bertsch, Uta
Zweegman, Sonja
Buijs, Arjan
Hose, Dirk
Lokhorst, Henk M.
Goldschmidt, Hartmut
Sonneveld, Pieter
BLOOD, 2013, 121 (04) : 624 - 627
[39] Tumor lysis syndrome in a multiple myeloma treated with thalidomide
Fuente, N
Mañe, JM
Barcelo, R
Muñoz, A
Perez-Hoyos, T
Lopez-Vivanco, G
ANNALS OF ONCOLOGY, 2004, 15 (03) : 537 - 537
[40] Genetic Variations Associated with Overall and Progression-Free Survival in Multiple Myeloma Patients Treated with Thalidomide Combinations
Johnson, David C.
Gregory, Walter M.
Dickens, Nicholas J.
Walker, Brian A.
Szubert, Alex J.
Davies, Faith E.
Durie, Brian G. M.
Van Ness, Brian G.
Morgan, Gareth J.
BLOOD, 2009, 114 (22) : 177 - 177

← 1 2 3 4 5 →